Emily Faucette

Investor Relations Contact at TALIS BIOMEDICAL CORPORATION

Health Technology

Consumer Services

Emily Faucette active positions

Companies	Position	Start	End
TALIS BIOMEDICAL CORPORATION	Investor Relations Contact	2020-12-31	-
TALIS BIOMEDICAL CORPORATION	Public Communications Contact	2020-12-31	-

Companies	Position	Start	End
PORTOLA PHARMACEUTICALS, INC.	Investor Relations Contact	2020-01-31	2020-06-30
GENOMIC HEALTH, INC.	Investor Relations Contact	-	-
GENOMIC HEALTH, INC.	Public Communications Contact	-	-

American University

Undergraduate Degree

International

United States

Operational

Investor Relations Contact	3
Public Communications Contact	2
Undergraduate Degree	1

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
TALIS BIOMEDICAL CORPORATION	Health Technology

Private companies	2
Genomic Health, Inc. Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.	Health Technology
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology

Private companies

Health Technology